BRIGHT MINDS BIOSCIENCES INC. financial data

Symbol
DRUG on Nasdaq
Location
New York, NY
Fiscal year end
30 September
Latest financial report
20-F - Q3 2024 - 31 Dec 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,524,087 shares 1.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets CA$6,104,602 CAD -11%
Liabilities CA$568,259 CAD 102%